Table 4.
Treatment2 | SEM | P-value | |||||
---|---|---|---|---|---|---|---|
CON | SCFP14 | SCFP28 | CON vs. SCFP14 | SCFP14 vs. SCFP28 | Day4 | ||
Blood component5 | |||||||
WBC, 103/µL | 12.1 | 12.1 | 11.9 | 0.30 | 0.94 | 0.62 | 0.01 |
RBC, 106/µL | 9.4 | 9.4 | 9.4 | 0.07 | 0.81 | 0.99 | 0.07 |
Hemoglobin, g/dL | 13.4 | 13.3 | 13.4 | 0.11 | 0.45 | 0.50 | 0.01 |
Hematocrit, % | 37.2 | 36.9 | 37.4 | 0.34 | 0.52 | 0.26 | 0.01 |
Platelets, 103/µL | 499 | 575 | 531 | 34.3 | 0.11 | 0.34 | 0.36 |
Neutrophils, 103/µL | 4.0 | 4.0 | 4.0 | 0.22 | 0.94 | 0.94 | 0.01 |
Eosinophils, 103/µL | 0.2 | 0.2 | 0.2 | 0.02 | 0.86 | 0.25 | 0.06 |
Basophils, 103/µL | 0.1 | 0.1 | 0.1 | 0.01 | 0.59 | 0.17 | 0.03 |
Lymphocytes, 103/µL | 6.9 | 7.0 | 6.8 | 0.19 | 0.63 | 0.55 | 0.01 |
Monocytes, 103/µL | 0.7 | 0.7 | 0.7 | 0.02 | 0.83 | 0.90 | 0.01 |
Serum | |||||||
IL-8, pg/mL | 255 | 218 | 295 | 35.4 | 0.35 | 0.08 | 0.01 |
Haptoglobin, mg/dL | 14.7 | 13.9 | 17.9 | 1.71 | 0.67 | 0.07 | 0.01 |
1Vaccination given on day 34. Blood samples from days 3, 6, 9, 11, and 14 post vaccination. Data from blood samples taken prior to vaccination used as a covariate in analysis.
2CON = Original XPC (Diamond V, Cedar Rapids, IA) at 0 g·steer−1·d−1; SCFP14 = Original XPC at 14 g·steer−1·d−1; SCFP28 = Original XPC at 28 g·steer−1·d−1.
3Highest SEM of any treatment reported.
4Based on repeated measures analysis; treatment × day P ≥ 0.28 for all variables.
5WBC = white blood cells; RBC = red blood cells; WBC, neutrophils, eosinophils, monocytes, IL-8, and haptoglobin natural log transformed; back-transformed means and SEM presented.